Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
about
Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma.Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).Endothelial Ca2+ Signaling and the Resistance to Anticancer Treatments: Partners in Crime.
P2860
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
@en
type
label
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
@en
prefLabel
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
@en
P2093
P2860
P1476
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
@en
P2093
Camillo Porta
Chiara Paglino
Palma Giglione
P2860
P304
P356
10.1517/14656566.2016.1127353
P407
P577
2015-12-02T00:00:00Z